NUCLEAR-MAGNETIC-RESONANCE INVESTIGATION OF THE STOICHIOMETRIES IN BETA-CYCLODEXTRIN - STEROID INCLUSION COMPLEXES

被引:56
作者
DJEDAINI, F
PERLY, B
机构
[1] Service de Chimie Moléculaire, Centre D'etudes Nucléaires de Saclay, Gif Sur Yvette
关键词
D O I
10.1002/jps.2600801213
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nuclear magnetic resonance at high field has been used to investigate the stoichiometries of pharmacologically important beta-cyclodextrin:steroid complexes. This technique provides evidence for the existence of true inclusion complexes and allows unequivocal determination of the stoichiometry for complexes obtained in the solid state, as well as in solution. The present data clarify previously published determinations of the stoichiometry of these complexes and show the influence of the nature and position of functional groups on the molecular ratio in the complex. The observed behavior can be rationalized using representative steroids and allows prediction of the strength of inclusion and the most probable stoichiometry.
引用
收藏
页码:1157 / 1161
页数:5
相关论文
共 12 条
  • [1] MOLECULAR DISPOSITION OF SODIUM PARA-NITROPHENOLATE IN CAVITIES OF CYCLOHEPTAAMYLOSE AND CYCLOHEXAAMYLOSE IN SOLUTION
    BERGERON, R
    ROWAN, R
    [J]. BIOORGANIC CHEMISTRY, 1976, 5 (04) : 425 - 436
  • [2] HIGH-FIELD NUCLEAR-MAGNETIC-RESONANCE TECHNIQUES FOR THE INVESTIGATION OF A BETA-CYCLODEXTRIN-INDOMETHACIN INCLUSION COMPLEX
    DJEDAINI, F
    LIN, SZ
    PERLY, B
    WOUESSIDJEWE, D
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) : 643 - 646
  • [3] DJEDAINI F, 1990, 6TH P INT S MOL REC, pL14
  • [4] FRANK SG, 1983, J PHARM SCI, V10, P1215
  • [5] Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117
  • [6] HILDEBRAND JA, 1949, J AM CHEM SOC, V72, P2703
  • [7] Job P, 1928, ANN CHIM FRANCE, V9, P113
  • [8] THE BINDING OF FLUORESCENT 4,6,8(14)-TRIENE-3-ONE STEROIDS TO CYCLODEXTRINS AS A MODEL FOR STEROID PROTEIN INTERACTIONS
    KEMPFLE, MA
    MULLER, RF
    PALLUK, R
    WINKLER, HA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 923 (01) : 83 - 87
  • [9] UEKAMA K, 1982, INT J PHARMACEUT, V10, P1
  • [10] UEKAMA K, 1985, PHARM ACTA HELV, V60, P117